新型冠状病毒肺炎患者接受静脉-静脉体外膜氧合期间俯卧位通气的有益效果
该观察性研究纳入2020年2月16日至10月31日期间72家国际机构中接受静脉-静脉体外膜氧合支持的新型冠状病毒肺炎患者232例,比较体外膜氧合期间使用或不使用俯卧位通气的结局。体外膜氧合期间使用俯卧位通气者67例(29%),体外膜氧合前使用俯卧位通气者176例(76%)。体外膜氧合俯卧位组出院生存率为33%,体外膜氧合仰卧位组为22%。体外膜氧合期间俯卧位通气与死亡率降低相关(HR 0.31;95%CI 0.14-0.68)。作者认为,鉴于研究的观察性性质,需要随机对照试验来证实这些发现。
要点
- 在72家国际机构注册的232例新型冠状病毒肺炎静脉-静脉体外膜氧合患者中,体外膜氧合期间使用俯卧位通气者67例(29%)。
- 体外膜氧合俯卧位组出院生存率为33%,体外膜氧合仰卧位组为22%。
- 体外膜氧合期间俯卧位通气与死亡率降低相关(HR 0.31;95%CI 0.14-0.68)。
- 体外膜氧合前使用俯卧位通气者176例(76%)。
- 作者认为,鉴于研究的观察性性质,需要随机对照试验来证实这些发现。
适用人群与场景
- 2020年2月16日至10月31日期间,72家参与新型冠状病毒肺炎重症监护联盟国际注册研究的机构中,接受静脉-静脉体外膜氧合支持的新型冠状病毒肺炎患者232例。
研究设计与关键结果
- 研究类型为观察性研究,采用多状态生存模型比较体外膜氧合期间使用或不使用俯卧位通气的结局,并调整潜在混杂因素。
- 共纳入232例接受静脉-静脉体外膜氧合的新型冠状病毒肺炎患者,来自72家参与机构。
- 体外膜氧合前使用俯卧位通气者176例(76%),体外膜氧合期间使用俯卧位通气者67例(29%)。
- 体外膜氧合俯卧位组出院生存率为33%,体外膜氧合仰卧位组为22%。
- 体外膜氧合期间俯卧位通气与死亡率降低相关(HR 0.31;95%CI 0.14-0.68)。
证据类型、等级与局限
- 证据类型:观察性研究。
- 作者指出,鉴于研究的观察性性质,需要随机对照试验来证实这些发现。
对床旁实践的改变
- 作者认为,对于难治性新型冠状病毒肺炎相关急性呼吸窘迫综合征接受静脉-静脉体外膜氧合支持的患者,体外膜氧合期间俯卧位通气与死亡率降低相关。
- 作者指出,鉴于研究的观察性性质,需要随机对照试验来证实这些发现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The study investigated the impact of prone positioning during venovenous extracorporeal membrane oxygenation support for coronavirus disease 2019 acute respiratory failure on the patient outcome.
DESIGN: An observational study of venovenous extracorporeal membrane oxygenation patients. We used a multistate survival model to compare the outcomes of patients treated with or without prone positioning during extracorporeal membrane oxygenation, which incorporates the dynamic nature of prone positioning and adjusts for potential confounders.
SETTING: Seventy-two international institutions participating in the Coronavirus Disease 2019 Critical Care Consortium international registry.
PATIENTS: Coronavirus disease 2019 patients who were supported by venovenous extracorporeal membrane oxygenation during the study period.
MEASUREMENTS AND MAIN RESULTS: There were 232 coronavirus disease 2019 patients at 72 participating institutions who were supported with venovenous extracorporeal membrane oxygenation during the study period from February 16, 2020, to October 31, 2020. Proning was used in 176 patients (76%) before initiation of extracorporeal membrane oxygenation and in 67 patients (29%) during extracorporeal membrane oxygenation. Survival to hospital discharge was 33% in the extracorporeal membrane oxygenation prone group versus 22% in the extracorporeal membrane oxygenation supine group. Prone positioning during extracorporeal membrane oxygenation support was associated with reduced mortality (hazard ratio, 0.31; 95% CI, 0.14-0.68).
CONCLUSIONS: Our study highlights that prone positioning during venovenous extracorporeal membrane oxygenation support for refractory coronavirus disease 2019-related acute respiratory distress syndrome is associated with reduced mortality. Given the observational nature of the study, a randomized controlled trial of prone positioning on venovenous extracorporeal membrane oxygenation is needed to confirm these findings.
参考来源
- Zaaqoq AM, Barnett AG, Griffee MJ, et al. Beneficial Effect of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019. Crit Care Med. 2022. PMID: 34582415. doi:10.1097/CCM.0000000000005296
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。